These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25245290)

  • 1. K-rasG12V mediated lung tumor models identified three new quantitative trait loci modifying events post-K-ras mutation.
    Saito H; Suzuki N
    Biochem Biophys Res Commun; 2014 Oct; 452(4):1067-70. PubMed ID: 25245290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of promoter and intron 2 polymorphisms on murine lung K-ras gene expression.
    Jones-Bolin SE; Johansson E; Palmisano WA; Anderson MW; Wiest JS; Belinsky SA
    Carcinogenesis; 1998 Aug; 19(8):1503-8. PubMed ID: 9744549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene.
    Lin L; Festing MF; Devereux TR; Crist KA; Christiansen SC; Wang Y; Yang A; Svenson K; Paigen B; Malkinson AM; You M
    Exp Lung Res; 1998; 24(4):481-97. PubMed ID: 9659579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mouse models of K-ras-initiated oncogenesis].
    Barrière C; Marjou FE; Louvard D; Robine S
    Bull Cancer; 2009 Dec; 96 Suppl():S5-14. PubMed ID: 20034865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- b1 haploinsufficiency.
    Pandey J; Umphress SM; Kang Y; Angdisen J; Naumova A; Mercer KL; Jacks T; Jakowlew SB
    Carcinogenesis; 2007 Dec; 28(12):2589-96. PubMed ID: 17690114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
    Jackson EL; Willis N; Mercer K; Bronson RT; Crowley D; Montoya R; Jacks T; Tuveson DA
    Genes Dev; 2001 Dec; 15(24):3243-8. PubMed ID: 11751630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
    Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
    Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
    Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines.
    Wang M; Lemon WJ; Liu G; Wang Y; Iraqi FA; Malkinson AM; You M
    Cancer Res; 2003 Jun; 63(12):3317-24. PubMed ID: 12810665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma.
    Okudela K; Hayashi H; Ito T; Yazawa T; Suzuki T; Nakane Y; Sato H; Ishi H; KeQin X; Masuda A; Takahashi T; Kitamura H
    Am J Pathol; 2004 Jan; 164(1):91-100. PubMed ID: 14695323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors.
    Manenti G; Trincucci G; Pettinicchio A; Amendola E; Scarfò M; Dragani TA
    Oncogene; 2008 Sep; 27(43):5753-8. PubMed ID: 18560355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras.
    McKenna IM; Ramakrishna G; Diwan BA; Kang Y; Shiao YH; Wakefield LM; Powell DA; Anderson LM; Jakowlew SB
    Toxicol Lett; 2001 Sep; 123(2-3):151-8. PubMed ID: 11641043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
    Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
    Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel oncogenic K-ras mutation in colon cancer.
    Akagi K; Uchibori R; Yamaguchi K; Kurosawa K; Tanaka Y; Kozu T
    Biochem Biophys Res Commun; 2007 Jan; 352(3):728-32. PubMed ID: 17150185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
    Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
    Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ
    J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting KRAS mutation-bearing lung cancer in vivo by pulmonary surfactant-adenovirus-mediated gene transfer.
    Fukazawa T; Maeda Y; Matsuoka J; Ono T; Mominoki K; Yamatsuji T; Shigemitsu K; Morita I; Murakami I; Tanaka H; Durbin ML; Naomoto Y
    Anticancer Res; 2010 Dec; 30(12):4925-35. PubMed ID: 21187472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genetic polymorphisms through comparative DNA sequence analysis on the K-ras gene: implications for lung tumor susceptibility.
    Wang M; Wang Y; You M
    Exp Lung Res; 2005 Mar; 31(2):165-77. PubMed ID: 15824019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.